Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for HUTCHMED (China) (HCM) over the last 11 years, with Q2 2025 value amounting to $5.1 million.

  • HUTCHMED (China)'s Other Accumulated Expenses fell 1544.94% to $5.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.1 million, marking a year-over-year decrease of 1544.94%. This contributed to the annual value of $4.5 million for FY2024, which is 52813.4% up from last year.
  • Per HUTCHMED (China)'s latest filing, its Other Accumulated Expenses stood at $5.1 million for Q2 2025, which was down 1544.94% from $4.5 million recorded in Q4 2024.
  • In the past 5 years, HUTCHMED (China)'s Other Accumulated Expenses ranged from a high of $37.2 million in Q2 2022 and a low of -$87000.0 during Q4 2021
  • Over the past 5 years, HUTCHMED (China)'s median Other Accumulated Expenses value was $5.8 million (recorded in 2021), while the average stood at $8.5 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first tumbled by 17187.5% in 2021, then skyrocketed by 244942.53% in 2022.
  • HUTCHMED (China)'s Other Accumulated Expenses (Quarter) stood at -$87000.0 in 2021, then soared by 2449.43% to $2.0 million in 2022, then soared by 412.52% to $10.5 million in 2023, then plummeted by 57.29% to $4.5 million in 2024, then increased by 14.37% to $5.1 million in 2025.
  • Its Other Accumulated Expenses stands at $5.1 million for Q2 2025, versus $4.5 million for Q4 2024 and $6.1 million for Q2 2024.